FDA Recalls Various OTC Skin Creams Over Manufacturing Concerns

The FDA has issued Class II recalls for numerous private label over-the-counter antibiotic, antifungal, and hydrocortisone creams. These products, manufactured by Dabur India Limited and sold under various brands in the U.S., are being pulled due to serious manufacturing violations. Additionally, the Dabur India facility has been placed on an import alert, indicating broader quality control issues.